Molecular Imaging & Therapy Service Training Programs: Research

Trainees are encouraged to participate in and present research at various national and international conferences. In addition, research opportunities in the use of experimental PET radiopharmaceuticals in novel cancer therapy trials and the role of PET-CT and imaging biomarkers for early cancer therapy response assessment are available. Below are selected publications from our residents and faculty from 2010–2014.

Selected Publications

Ho AL, Grewal RK, Leboeuf R, Sherman EJ, Pfister DG, Deandreis D, Pentlow KS, Zanzonico PB, Haque S, Gavane S, Ghossein RA, Ricarte-Filho JC, Domínguez JM, Shen R, Tuttle RM, Larson SM, Fagin JA. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. N Engl J Med. 2013 Feb 14;368(7):623-32.

Beylergil V, Simmons MZ, Ulaner G, Jurcic J, Hibshoosh H, Carrasquillo JA. FDG PET/CT Findings in a Rare Case of Giant Fibrovascular Polyp of the Esophagus Harboring Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma. Clin Nucl Med. 2014 Mar;39(3):288-91.

Kang HJ, Beylergil V, Price AP, Abramson SJ, Carrasquillo JA. FDG PET/CT detection of intussusception caused by lymphoma in a pediatric patient. Clin Nucl Med. 2014 Jan;39(1):97-8.

Beylergil V, Sofocleous CT, Carrasquillo JA. Extrahepatic visualization in the distribution of falciform artery in posttreatment Bremsstrahlung images after radioembolization with (90)Y microspheres. Rev Esp Med Nucl Imagen Mol. 2014 Jan 14.

Thorek DL, Riedl CC, Grimm J. Clinical Cerenkov luminescence imaging of (18)F-FDG. J Nucl Med. 2014 Jan;55(1):95-8. doi: 10.2967/jnumed.113.127266. Epub 2013 Sep 27.

Beylergil V, Haque S, Carver A, Bilsky MH, Carrasquillo JA. Schwannomatosis/neurofibromatosis type 2 associated multiple schwannomas visualized on FDG-PET/CT. Rev Esp Med Nucl Imagen Mol. 2013 Jul-Aug;32(4):275-6.

Beylergil V, Morris PG, Smith-Jones PM, Modi S, Solit D, Hudis CA, Lu Y, O'Donoghue J, Lyashchenko SK, Carrasquillo JA, Larson SM, Akhurst TJ. Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer. Nucl Med Commun. 2013 Dec;34(12):1157-65.

Heiba S, Kolker D, Ong L, Sharma S, Travis A, Teodorescu V, Ellozy S, Kostakoglu L, Savitch I, Machac J. Dual-isotope SPECT/CT impact on hospitalized patients with suspected diabetic foot infection: saving limbs, lives, and resources. Nucl Med Commun. 2013 Sep;34(9):877-84.

Ulaner GA, Lyall A. “Identifying and Distinguishing Treatment Effects and Complications from Malignancy at FDG PET/CT.” Radiographics33, no. 6 (2013): 1817-1834.

Lyall A, Vargas HA, Carvajal RD, Ulaner G. Ipilimumab Induced Colitis on FDG PET/CT. Clin Nucl Med. 2012; 37:629-30.

Khadraoui H, Feigin KN, Fox JJ, Ong L, Shike M, Yahalom J, Noy A. Successful management of gastric perforation in stage IV diffuse large B-cell lymphoma with chemoradiation therapy, percutaneous endoscopy gastrostomy for gastric drainage, and percutaneous endoscopy jejunostomy for nutrition. Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):327-30. doi: 10.1016/j.clml.2012.11.005. Epub 2012 Dec 23.

Dharmarajan KV, Wexler LH, Gavane S, Fox JJ, Schoder H, Tom AK, Price AN, Meyers PA, Wolden SL. Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):996-1002.

Lu Y; Fleming SE, Fields RC, Coit DG, Carrasquillo JA. Comparison of F-18-FDG PET/CT and In-111-Pentetreotide Scan for Detection of Merkel Cell Carcinoma. Clin Nucl Med. 37 (8):759-762. 2012.   

Lim R, Carrasquillo JA. 18F-FDG Uptake in Metaphyseal Growth Arrest Lines: A Case Study. Clin Nucl Med. 37 (10): 993-4. 2012.

Lyall A, Ulaner GA. False Positive FDG PET/CT Due to Liver Parenchymal Injury Caused By a Surgical Retractor. Clin Nucl Med. 2012 Sep;37(9):910-1.

Lyall A, Capobianco J, Strauss HW, Gonen M, Schöder H. Treadmill exercise inducing mild to moderate ischemia has no significant effect on skeletal muscle or cardiac 18F-FDG uptake and image quality on subsequent whole-body PET scan. J Nucl Med 2012; 53:917-21.

Fox JJ, Autran-Blanc E, Morris MJ, Gavane S, Nehmeh S, Van Nuffel A, Gönen M, Schöder H, Humm JL, Scher HI, Larson SM. Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT. J Nucl Med. 2011 Nov;52(11):1727-32.

Lu Y, Ulaner GA. FDG PET/CT demonstration of right atrium metastasis overlooked on contrast-enhanced CT. Clin Nucl Med. 2011 May;36(5):405-6.

Abraham T, Schöder H. Thyroid cancer—indications and opportunities for positron emission tomography/computed tomography imaging. Semin Nucl Med. 2011 Mar;41(2):121-38.

Riedl CC, Akin O, Ishill NM, Moskowitz CS, Zhang J, Hricak H. Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer. Eur Radiol. 2010 Apr;20(4):995-1002.

Strong VE, Galanis CJ, Riedl CC, Longo VA, Daghighian F, Humm JL, Larson SM, Fong Y. Portable PET probes are a novel tool for intraoperative localization of tumor deposits. Ann Surg Innov Res. 2009 Feb 21;3:2.

Riedl CC, Brader P, Zanzonico PB, Chun YS, Woo Y, Singh P, Carlin S, Wen B, Ling CC, Hricak H, Fong Y. Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET. Radiology. 2008 Aug;248(2):561-70.